We are live on ! Find out more
PRPH

ProPhase Labs
PRPH

Delisted

PRPH was delisted on the 2nd of January, 2026.

Back to rankings

14 hedge funds and large institutions have $1.98M invested in ProPhase Labs in 2014 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

8% more funds holding

Funds holding: 13 → 14 (+1)

16% less capital invested

Capital invested by funds: $2.35M → $1.98M (-$374K)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
14
Holders Change
+1
Holders Change %
+7.69%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$9.81K
2
Federated Hermes
Federated Hermes
Pennsylvania
+$4.09K
3
BIM
BlackRock Investment Management
Delaware
+$3.5K
4
TRCT
Tower Research Capital (TRC)
New York
+$444

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$21.4K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$7.4K
3
U
UBS
Switzerland
-$3.59K

PRPH Hedge Fund Activity: Q2 2014 in Review

14 of the 3,490 institutional investors tracked by Wall St. Rank reported a position in ProPhase Labs (PRPH) for Q2 2014, worth a combined $1.98M — down 16% from $2.35M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new PRPH positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 3 trimmed.

The largest buyer was Vanguard Group, adding an estimated $9.81K. The largest seller was Renaissance Technologies, cutting an estimated $21.4K.

  • 14 institutional investors held ProPhase Labs (PRPH) as of Q2 2014, up from 13 in Q1 2014.
  • Funds reported $1.98M of ProPhase Labs stock for Q2 2014, down 16% quarter-over-quarter.
  • 3 funds opened new ProPhase Labs positions in Q2 2014 and 2 closed out, a net change of +1 holder.
  • The largest ProPhase Labs buyer in Q2 2014 was Vanguard Group, an estimated $9.81K added.
  • The largest ProPhase Labs seller in Q2 2014 was Renaissance Technologies, an estimated $21.4K sold.

Based on aggregated 13F filings for Q2 2014.